• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

J Clin Med . Seroprevalence of SARS-CoV-2 Antibodies and Factors Associated with Seropositivity at the University of Salamanca: The DIANCUSAL Study

tetano

Editor, Senior Moderator
J Clin Med


. 2021 Jul 21;10(15):3214.
doi: 10.3390/jcm10153214.
Seroprevalence of SARS-CoV-2 Antibodies and Factors Associated with Seropositivity at the University of Salamanca: The DIANCUSAL Study


Antonio Muro[SUP] 1 [/SUP], Moncef Belhassen-García[SUP] 1 [/SUP], Juan Luís Muñoz Bellido[SUP] 2 3 4 [/SUP], Helena Lorenzo Juanes[SUP] 2 3 4 [/SUP], Belén Vicente[SUP] 1 [/SUP], Josué Pendones[SUP] 2 3 4 [/SUP], José Adserias[SUP] 5 [/SUP], Gonzalo Sánchez Hernández[SUP] 6 [/SUP], Miguel Rodríguez Rosa[SUP] 7 [/SUP], José Luis Vicente Villardón[SUP] 7 [/SUP], Javier Burguillo[SUP] 8 [/SUP], Javier López Andaluz[SUP] 9 [/SUP], Jose Angel Martín Oterino[SUP] 2 10 [/SUP], Francisco Javier García Criado[SUP] 2 [/SUP], Fausto Barbero[SUP] 9 [/SUP], Ana Isabel Morales[SUP] 2 11 [/SUP], Purificación Galindo Villardón[SUP] 7 [/SUP], Rogelio González Sarmiento[SUP] 2 12 [/SUP], On Behalf Of The Diancusal Team



Affiliations
Free article

Abstract

Background: Systematic screening for antibodies against SARS-CoV-2 is a crucial tool for surveillance of the COVID-19 pandemic. The University of Salamanca (USAL) in Spain designed a project called "DIANCUSAL" (Diagnosis of New Coronavirus, COVID-19, in University of Salamanca) to measure antibodies against SARS-CoV-2 among its ~34,000 students and academic staff, as the influence of the university community in the spread of the SARS-CoV-2 pandemic in the city of Salamanca and neighboring towns hosting USAL campuses could be substantial.
Objective: The aim of this study was to estimate the prevalence of SARS-CoV-2 antibodies among USAL students, professors and staff and to evaluate the demographic, academic, clinical and lifestyle and behavioral factors related to seropositivity.
Methodology: The DIANCUSAL study is an ongoing university population-based cross-sectional study, with the work described herein conducted from July-October 2020. All USAL students, professors and staff were invited to complete an anonymized questionnaire. Seroprevalence of anti-SARS-CoV-2 antibodies was detected and quantified by using chemiluminescent assays for IgG and IgM.
Principal findings: A total of 8197 (24.71%) participants were included. The mean age was 31.4 (14.5 SD) years, and 66.0% of the participants were female. The seroprevalence was 8.25% overall and was highest for students from the education campus (12.5%) and professors from the biomedical campus (12.6%), with significant differences among faculties (p = 0.006). Based on the questionnaire, loss of smell and fever were the symptoms most strongly associated with seropositivity, and 22.6% of seropositive participants were asymptomatic. Social distancing was the most effective hygiene measure (p = 0.0007). There were significant differences in seroprevalence between participants with and without household exposure to SARS-CoV-2 (p = 0.0000), but not between students who lived in private homes and those who lived in dormitories. IgG antibodies decreased over time in the participants with confirmed self-reported COVID-19 diagnoses.
Conclusions: The analysis revealed an overall 8.25% seroprevalence at the end of October 2020, with a higher seroprevalence in students than in staff. Thus, there is no need for tailored measures for the USAL community as the official average seroprevalence in the area was similar (7.8% at 22 June and 12.4 at 15 November of 2020). Instead, USAL members should comply with public health measures.

Keywords: COVID-19; SARS-CoV-2; Salamanca; Spain; antibodies; screening; seroprevalence; university.
 
Back
Top Bottom